Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Expert Opinion on Pharmacotherapy|March 30, 2005
Enfuvirtide: the first HIV fusion inhibitorAdriano Lazzarin
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced diseaseAlessandro Soria, Adriano Lazzarin
The New Microbiologica|January 3, 2006
Sequencing antiretroviral drugs for long-lasting suppression of HIV replicationNicola Gianotti, Adriano Lazzarin
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Genotypic resistance tests for the clinical management of patients with primary HIV infectionPasquale Narciso, Adriano Lazzarin
Blood|September 21, 2004
CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjectsClaudia Barassi, Adriano Lazzarin, Lucia Lopalco
Expert Opinion on Pharmacotherapy|May 3, 2007
Access denied? The status of co-receptor inhibition to counter HIV entryPriscilla Biswas, Giuseppe Tambussi, Adriano Lazzarin
Current Opinion in HIV and AIDS|May 11, 2018
BictegravirVincenzo Spagnuolo, Antonella Castagna, Adriano Lazzarin
Expert Opinion on Pharmacotherapy|June 19, 2018
Darunavir for the treatment of HIV infectionVincenzo Spagnuolo, Antonella Castagna, Adriano Lazzarin
European Journal of Medical Research|December 5, 2009
Raltegravir in treatment naive patientsF Cossarini, A Castagna, Adriano Lazzarin
The New Microbiologica|September 30, 2015
stARTing cART now! HIV treatment Italian Guidelines Update Dec. 2014Adriano Lazzarin, Andrea Antinori, Simone Marcotullio
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Expert Opinion on Pharmacotherapy|March 30, 2005
Enfuvirtide: the first HIV fusion inhibitorAdriano Lazzarin
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced diseaseAlessandro Soria, Adriano Lazzarin
The New Microbiologica|January 3, 2006
Sequencing antiretroviral drugs for long-lasting suppression of HIV replicationNicola Gianotti, Adriano Lazzarin
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Genotypic resistance tests for the clinical management of patients with primary HIV infectionPasquale Narciso, Adriano Lazzarin
Blood|September 21, 2004
CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjectsClaudia Barassi, Adriano Lazzarin, Lucia Lopalco
Expert Opinion on Pharmacotherapy|May 3, 2007
Access denied? The status of co-receptor inhibition to counter HIV entryPriscilla Biswas, Giuseppe Tambussi, Adriano Lazzarin
Current Opinion in HIV and AIDS|May 11, 2018
BictegravirVincenzo Spagnuolo, Antonella Castagna, Adriano Lazzarin
Expert Opinion on Pharmacotherapy|June 19, 2018
Darunavir for the treatment of HIV infectionVincenzo Spagnuolo, Antonella Castagna, Adriano Lazzarin
European Journal of Medical Research|December 5, 2009
Raltegravir in treatment naive patientsF Cossarini, A Castagna, Adriano Lazzarin
The New Microbiologica|September 30, 2015
stARTing cART now! HIV treatment Italian Guidelines Update Dec. 2014Adriano Lazzarin, Andrea Antinori, Simone Marcotullio
Pageof 33